What does JMT Health and Quality do?

JMT Health and Quality is filed with the CBE under the catch-all “Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten”, a code that says little about what the company actually does. Private Limited, started on 11 January 2019, 1 establishment.

What is the address of JMT Health and Quality?

The registered office of JMT Health and Quality is located at Marloie, Rue des Montenées 3, 6900 Marche-en-Famenne.

Is JMT Health and Quality still active?

Yes. According to the CBE (18 September 2026) JMT Health and Quality is active, legal situation “Normale toestand”, started on 11 January 2019.

Is JMT Health and Quality registered on Peppol?

Yes, JMT Health and Quality is registered on the Peppol network with ID 0208:0717995879.

What is the enterprise number of JMT Health and Quality?

The enterprise number of JMT Health and Quality is BE0717995879.

When was JMT Health and Quality founded?

JMT Health and Quality was founded on 11 January 2019.

Who are the directors of JMT Health and Quality?

According to the 2025 annual accounts, the directors of JMT Health and Quality are: Jean-Marc Tilquin.

Is JMT Health and Quality a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 January 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JMT Health and Quality make in 2025?

JMT Health and Quality posted a profit after taxes of € 41,209 in financial year 2025.

What is the revenue of JMT Health and Quality?

As a small company, JMT Health and Quality is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 55,985.

JMT Health and Quality (Private Limited)

Dossier JMT Health and Quality, printed on 18 September 2026 from databakkes.be/en/0717995879/jmt-health-and-quality. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JMT Health and Quality from Marche-en-Famenne, company number BE0717995879, closed financial year 2025 with a result of € 41,209 after tax. For that financial year JMT Health and Quality recorded a gross margin of € 55,985 and equity of € 23,597. Compared with financial year 2024, the result moved from € 32,069 to € 41,209. Profitable, and profit is growing. The buffer shrank hard: equity is 57 % below last year. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on May 11, 2026.

What it is worth Shrank hard

€ 23,597

▼ 57% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 41,209

▲ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 133,232

▲ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 72,419 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 710

▼ 60% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,764

▼ 14% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,692

▼ 7% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 62,873 Gross margin 2022: € 62,873 First fiscal year in the series	€ 73,318 Gross margin 2023: € 73,318 ▲ 17% vs 2022 (€ 62,873) Favourable step	€ 44,340 Gross margin 2024: € 44,340 ▼ 40% vs 2023 (€ 73,318) Unfavourable step	€ 55,985 Gross margin 2025: € 55,985 ▲ 26% vs 2024 (€ 44,340) Favourable step	▲ 26%
Profit after taxes	€ 47,520 Profit after taxes 2022: € 47,520 First fiscal year in the series	€ 54,936 Profit after taxes 2023: € 54,936 ▲ 16% vs 2022 (€ 47,520) Favourable step	€ 32,069 Profit after taxes 2024: € 32,069 ▼ 42% vs 2023 (€ 54,936) Unfavourable step	€ 41,209 Profit after taxes 2025: € 41,209 ▲ 29% vs 2024 (€ 32,069) Favourable step	▲ 29%
Equity	€ 64,917 Equity 2022: € 64,917 First fiscal year in the series	€ 23,597 Equity 2023: € 23,597 ▼ 64% vs 2022 (€ 64,917) Unfavourable step	€ 54,807 Equity 2024: € 54,807 ▲ 132% vs 2023 (€ 23,597) Favourable step	€ 23,597 Equity 2025: € 23,597 ▼ 57% vs 2024 (€ 54,807) Unfavourable step	▼ 57%
Total debts	€ 91,853 Total debts 2022: € 91,853 First fiscal year in the series	€ 114,462 Total debts 2023: € 114,462 ▲ 25% vs 2022 (€ 91,853) Unfavourable step	€ 94,820 Total debts 2024: € 94,820 ▼ 17% vs 2023 (€ 114,462) Favourable step	€ 128,262 Total debts 2025: € 128,262 ▲ 35% vs 2024 (€ 94,820) Unfavourable step	▲ 35%
Cash	€ 117,178 Cash 2022: € 117,178 First fiscal year in the series	€ 82,689 Cash 2023: € 82,689 ▼ 29% vs 2022 (€ 117,178) Unfavourable step	€ 102,190 Cash 2024: € 102,190 ▲ 24% vs 2023 (€ 82,689) Favourable step	€ 133,232 Cash 2025: € 133,232 ▲ 30% vs 2024 (€ 102,190) Favourable step	▲ 30%
Retained profit	€ 52,517 Retained profit 2022: € 52,517 First fiscal year in the series	€ 4,997 Retained profit 2023: € 4,997 ▼ 90% vs 2022 (€ 52,517) Unfavourable step	€ 36,207 Retained profit 2024: € 36,207 ▲ € 31,210 vs 2023 (€ 4,997) Favourable step	€ 4,997 Retained profit 2025: € 4,997 ▼ 86% vs 2024 (€ 36,207) Unfavourable step	▼ 86%
Dividend	€ 78,817 Dividend 2022: € 78,817 First fiscal year in the series	€ 102,456 Dividend 2023: € 102,456 ▲ 30% vs 2022 (€ 78,817) Unchanged	€ 859 Dividend 2024: € 859 ▼ 99% vs 2023 (€ 102,456) Unchanged	€ 72,419 Dividend 2025: € 72,419 ▲ € 71,560 vs 2024 (€ 859) Unchanged	▲ € 71,560
Balance sheet total	€ 156,770 Balance sheet total 2022: € 156,770 First fiscal year in the series	€ 138,060 Balance sheet total 2023: € 138,060 ▼ 12% vs 2022 (€ 156,770) Unchanged	€ 149,627 Balance sheet total 2024: € 149,627 ▲ 8% vs 2023 (€ 138,060) Unchanged	€ 151,860 Balance sheet total 2025: € 151,860 ▲ 1% vs 2024 (€ 149,627) Unchanged	▲ 1%

Key figures of JMT Health and Quality, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JMT Health and Quality?

What happened at JMT Health and Quality in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 11, 2026 New annual accounts for financial year 2025: profit of € 41,209 (▲ 29% vs 2024). Source: NBB ↗
Jan 11, 2019 New establishment in Marche-en-Famenne. KBO
2019 Jean-Marc Tilquin became a director. NBB
Jan 11, 2019 Start of the company according to the CBE. KBO

In short

From € 47,520 profit in 2022 to € 41,209 profit in 2025.

Paid € 45,999 in corporate taxes since 2022.

Best year ever: 2023, with € 54,936 profit.

Paid out € 254,550 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at JMT Health and Quality? We notify you, reason included.

Follow JMT Health and Quality

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jean-Marc Tilquin

JMT Health and Quality

Behind JMT Health and Quality is Jean-Marc Tilquin.

See the full network in the app

Directors

According to the 2025 annual accounts

Jean-Marc Tilquin

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Marloie, Rue des Montenées 3

6900 Marche-en-Famenne

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0717.995.879

VAT number

BE 0717.995.879

Registered office

Marloie, Rue des Montenées 3, 6900 Marche-en-Famenne

Names & denominations

JMT Health and Quality

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

11 January 2019

Peppol

Active · Active since 9 Dec 2025

Contact

[email protected]

Activities · NACE

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

JMT Health and Quality

Financials

What happened to JMT Health and Quality?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions